Defining quality of care for children and adolescents with type 1 diabetes.
International Novo Nordisk Symposium on Diabetes in Chilhood and Adolescence. Copenhagen, DNK, 1997/11/07.
Recent years have seen an increase in awareness of the need to improve the quality of diabetes care for children and adolescents, as detailed in the Declaration of Kos, for example.
This paper addresses some quality-of-care principles and evaluates specific examples of current management, The meaning of the terms quality of care, ev idence-based medicine and cost-containment are examined, and the features central to the development and evaluation of quality health care (structure, process and outcome) are explored.
The practical aspects of diabetes care are reviewed in terms of the causes and prevention of early mortality, ambulatory vs inpatient care, the value of measuring HbA1c other metabolic control criteria (including the effect of patient selection, cultural, socioeconomic and biological differences) and clinical practice guidelines.
It is concluded that a multidisciplinary team provides the optimum context for diabetes management and that care must be family centred and multidimensional (i. e not focusing on HbA1c levels alone).
The task of improving diabetes care is massive and operates at all levels (individual, family, healthcare providers, national and international bodies), but offers significant improvements in quality and cost-effectiveness.
Mots-clés Pascal : Diabète insulinodépendant, Instruction déclaration, Qualité, Soin, Vie quotidienne, Equipe soignante, Multidisciplinaire, Participation, Milieu familial, Etude statistique, Evaluation, Canada, Amérique du Nord, Amérique, Enfant, Homme, Adolescent, Endocrinopathie, Immunopathologie, Maladie autoimmune, Kos
Mots-clés Pascal anglais : Insulin dependent diabetes, Declaration, Quality, Care, Daily living, Health care staff, Multidisciplinary, Participation, Family environment, Statistical study, Evaluation, Canada, North America, America, Child, Human, Adolescent, Endocrinopathy, Immunopathology, Autoimmune disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0025564
Code Inist : 002B21E01C. Création : 31/05/1999.